At the market opening, the AI medical sector emerged as a frontrunner, with Hongbo Pharmaceutical witnessing a surge of over 8%. Other stocks, including Heshi Ophthalmology, Gan & Lee Pharmaceuticals, Chuangye Huikang, Thalys Medical, and others, also demonstrated a robust upward trend. This wave of gains could be attributed to the "Implementation Plan for Digital and Intelligent Transformation of the Pharmaceutical Industry (2025-2030)" jointly issued by the Ministry of Industry and Information Technology and six other departments. The plan outlines the pilot application of "AI Empowering the Entire Pharmaceutical Industry Chain," heralding new avenues of development for the AI medical sector.
